Atossa Genetics Stock Filter Stocks by Fundamentals
| ATOS Stock | USD 1.22 0.03 2.52% |
Atossa Genetics fundamentals help investors to digest information that contributes to Atossa Genetics' financial success or failures. It also enables traders to predict the movement of Atossa Stock. The fundamental analysis module provides a way to measure Atossa Genetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atossa Genetics stock.
Atossa | Shares Owned by Institutions |
Atossa Genetics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Atossa Genetics from analyzing Atossa Genetics' financial statements. These drivers represent accounts that assess Atossa Genetics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Atossa Genetics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.0M | 4.2M | 13.3M | 10.7M | 12.4M | 16.6M | |
| Enterprise Value | (4.2M) | (6.1M) | 809.6K | (28.8M) | (33.1M) | (31.5M) |
Atossa Genetics Institutional Holders
Institutional Holdings refers to the ownership stake in Atossa Genetics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Atossa Genetics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Atossa Genetics' value.| Shares | Nuveen Asset Management, Llc | 2024-06-30 | 170.7 K | Citadel Advisors Llc | 2024-09-30 | 161.9 K | Qube Research & Technologies | 2024-06-30 | 157.4 K | Rhumbline Advisers | 2024-06-30 | 135.1 K | Mariner Wealth Advisors Llc | 2024-06-30 | 105.9 K | Bank Of America Corp | 2024-06-30 | 105.7 K | Goldman Sachs Group Inc | 2024-06-30 | 102.7 K | Two Sigma Investments Llc | 2024-09-30 | 96.2 K | Citigroup Inc | 2024-09-30 | 92 K | Blackrock Inc | 2024-06-30 | 9.2 M | Vanguard Group Inc | 2024-09-30 | 6.6 M |
Atossa Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 78.71 M | ||||
| Shares Outstanding | 125.8 M | ||||
| Shares Owned By Insiders | 0.05 % | ||||
| Shares Owned By Institutions | 28.20 % | ||||
| Number Of Shares Shorted | 12.77 M | ||||
| Price To Earning | (0.62) X | ||||
| Price To Book | 2.08 X | ||||
| EBITDA | (31.35 M) | ||||
| Net Income | (30.09 M) | ||||
| Cash And Equivalents | 125.54 M | ||||
| Cash Per Share | 0.99 X | ||||
| Total Debt | 5.24 M | ||||
| Current Ratio | 35.19 X | ||||
| Book Value Per Share | 0.59 X | ||||
| Cash Flow From Operations | (20.94 M) | ||||
| Short Ratio | 30.34 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 5.83 | ||||
| Number Of Employees | 12 | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 153.48 M | ||||
| Total Asset | 96.25 M | ||||
| Retained Earnings | (186.29 M) | ||||
| Working Capital | 112.63 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 2.5 M | ||||
| Net Asset | 96.25 M |
About Atossa Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atossa Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.